Is Monopar Therapeutics Inc. overvalued?

Monopar Therapeutics Inc. (MNPR) — key valuation metrics and fundamentals.

No verdict

Price

$113.04

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$757.3M

Dividend yield

0.0%

Return on equity

-12.8%

Sector

Healthcare

Fair value compares MNPR's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks